Clinical Trial Update: An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease [Phase 3]

View source ↗

Summary

An open-label extension trial evaluated the long-term safety of extended-release ropinirole (Ropinirole XL) in Parkinson's disease, with results posted after th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ropinirole XL (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Parkinson Disease, Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-12-24